Fibrosis and portal hypertension are considered risk factors for hepatic resection in cirrhotic patients with hepatocellular carcinoma. Nrf2 is a transcription factor mediated by oxidative stress that regulates the expression of a series of targets with a cytoprotective function and plays a role important in the pathogenesis of liver fibrosis. The present study was set up to investigate the effects of of modulation of the Nrf2/HO-1/CO pathway on liver fibrosis in rats. Liver fibrosis was induced by administration of CCl4 for eight weeks. Thereafter, rats were treated with CORMA1 2mg/kg for two weeks and undergone to partial hepatectomy (lateral left and median lobes, around 70% of liver volume). At 7,15 and 30 days the degree of hepatic regeneration will be analyzed by a volumetric study of the residual liver volume using the Ultrasound Imaging Facility (Fujifilm-Visualsonics Vevo 3100). The results support a role of modulation of the Nrf2/HO-1/CO pathway in the liver regeneration, and simultaneously demonstrate the therapeutic potential of CORMA1 in the treatment of this type of chronic liver disease.

Effects of modulation of the NRF/HO-1/CO pathway in fibrosis and hepatic regeneration / Pesce, A., Mangano, K., Fagone, P., Puleo, S.. - 71:2(2018), pp. 31-61. (14th Congress of the International Society for Experimental Microsurgery Debrecen (Hungary) ).

Effects of modulation of the NRF/HO-1/CO pathway in fibrosis and hepatic regeneration

Pesce A;
2018

Abstract

Fibrosis and portal hypertension are considered risk factors for hepatic resection in cirrhotic patients with hepatocellular carcinoma. Nrf2 is a transcription factor mediated by oxidative stress that regulates the expression of a series of targets with a cytoprotective function and plays a role important in the pathogenesis of liver fibrosis. The present study was set up to investigate the effects of of modulation of the Nrf2/HO-1/CO pathway on liver fibrosis in rats. Liver fibrosis was induced by administration of CCl4 for eight weeks. Thereafter, rats were treated with CORMA1 2mg/kg for two weeks and undergone to partial hepatectomy (lateral left and median lobes, around 70% of liver volume). At 7,15 and 30 days the degree of hepatic regeneration will be analyzed by a volumetric study of the residual liver volume using the Ultrasound Imaging Facility (Fujifilm-Visualsonics Vevo 3100). The results support a role of modulation of the Nrf2/HO-1/CO pathway in the liver regeneration, and simultaneously demonstrate the therapeutic potential of CORMA1 in the treatment of this type of chronic liver disease.
2018
14th Congress of the International Society for Experimental Microsurgery
04 Pubblicazione in atti di convegno::04b Atto di convegno in volume
Effects of modulation of the NRF/HO-1/CO pathway in fibrosis and hepatic regeneration / Pesce, A., Mangano, K., Fagone, P., Puleo, S.. - 71:2(2018), pp. 31-61. (14th Congress of the International Society for Experimental Microsurgery Debrecen (Hungary) ).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1777602
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact